Pillstats
Rx only · Tablet, Extended Release · Oral

Glipizide

Brands: Glucotrol Xl · Glipizide

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA10BB07
RxCUI (US)4821
US makers9 labelers
Packages48
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.108$0.216$0.324$0.432Apr 2025Mar 2026Jul 2026
$0.149
Latest avg · Jul 22, 2026
-60%
Since Apr 23, 2025
9
Active US suppliers
44%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

25K50K76K101K2025 Q12025 Q22025 Q32025 Q42026 Q1
84K
Rx · 2026 Q1
5.8M
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager11SUPPLYING
A-S Medication Solutionsunknown10SUPPLYING
Aurobindo Pharma Limitedunknown7SUPPLYING
NorthStar Rx LLCunknown5SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Northwind Health Company, LLCunknown4SUPPLYING
Roerigunknown3SUPPLYING
American Health Packagingunknown2SUPPLYING
St. Mary's Medical Park Pharmacyunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 24, 2025
    RESOLVEDShortage resolved: Glipizide Tablet, Extended Release (Pfizer Inc.)

    Glipizide Tablet, Extended Release — reported in shortage by Pfizer Inc.. Therapeutic category: Endocrinology/Metabolism.

  • Jul 24, 2025
    SHORTAGEDrug shortage: Glipizide Tablet, Extended Release (Pfizer Inc.)

    Glipizide Tablet, Extended Release — reported in shortage by Pfizer Inc.. Therapeutic category: Endocrinology/Metabolism.